Glucagon analogues

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9403894
APP PUB NO 20130157935A1
SERIAL NO

13702841

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides materials and methods for promoting weight loss or preventing weight gain without affecting glycemic control. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the glucagon-like peptide-1 (GLP-1) receptor as compared to human glucagon.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ZEALAND PHARMA A/S

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Daugaard, Jens Rosengren Virum, DK 12 458
Meier, Eddi Vaerløse, DK 22 755
Riber, Ditte Brønshøj, DK 48 1015
Skovgaard, Marie Copenhagen Ø, DK 13 480

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00